Supernus Pharm (SUPN) Posts Q3 Loss of 55c/Share

November 7, 2012 7:50 AM

Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.55), $0.07 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.

No results found